This therapeutic effect is mainly mediated by adrenocorticotropic hormone (ACTH) secreted from the grafted corticotrophs, suggesting that the enrichment of functional pituitary cells from HP organoids is a promising step toward regenerative medicine for hypopituitarism. Here, POMC is linked to hypopituitarism.